Arctic Bioscience AS is a Norwegian biotechnology company that develops and commercializes nutraceutical and pharmaceutical ingredients derived from bioactive marine compounds, particularly herring roe. Founded in 2011, the company is focused on innovative health solutions, including the development of HRO350, a novel oral treatment for mild-to-moderate psoriasis. Arctic Bioscience operates under the brand Romega, offering high-DHA marine Omega-3 phospholipid extracts globally.